Arkolith/Insider Trading/MDGL/Form 4

Huntsman Carole

Chief Commercial OfficerMADRIGAL PHARMACEUTICALS, INC. (MDGL) · full profile →Form 4 · filed Jan 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$449K
Net Open-Market Flow
-$449K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2026Sell(S)570$494.59$282K9K
Jan 26, 2026Sell(S)340$492.42$167K10K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-003482) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML